| Denise Gamboa, OD | |
|
1051 Solano Ave, Albany, CA 94706-1650 | |
| (510) 526-3937 | |
| Not Available |
| Full Name | Denise Gamboa |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 1051 Solano Ave, Albany, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235618356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 34029 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ruth J Chen Od Inc | 5294127510 | 3 |
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
While many pharmaceutical and biologics companies are getting accustomed to FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) programs for many new and old drugs, most are not adequately preparing for the equally mandatory program evaluations beginning just 1-1/2 years after each REMS is put into effect.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering Atrial Fibrillation. These are the first guidelines to be prepared solely by the ESC on this very important topic.
› Verified 5 days ago
| Provider Name | Permanente Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
While many pharmaceutical and biologics companies are getting accustomed to FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) programs for many new and old drugs, most are not adequately preparing for the equally mandatory program evaluations beginning just 1-1/2 years after each REMS is put into effect.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering Atrial Fibrillation. These are the first guidelines to be prepared solely by the ESC on this very important topic.
› Verified 5 days ago
| Provider Name | Solano Eyecare Optometric Professionals |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316005671 PECOS PAC ID: 5092618173 Enrollment ID: O20040127001248 |
News Archive
While many pharmaceutical and biologics companies are getting accustomed to FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) programs for many new and old drugs, most are not adequately preparing for the equally mandatory program evaluations beginning just 1-1/2 years after each REMS is put into effect.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering Atrial Fibrillation. These are the first guidelines to be prepared solely by the ESC on this very important topic.
› Verified 5 days ago
| Provider Name | Redwood Eye Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023061306 PECOS PAC ID: 8224139969 Enrollment ID: O20070724000700 |
News Archive
While many pharmaceutical and biologics companies are getting accustomed to FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) programs for many new and old drugs, most are not adequately preparing for the equally mandatory program evaluations beginning just 1-1/2 years after each REMS is put into effect.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering Atrial Fibrillation. These are the first guidelines to be prepared solely by the ESC on this very important topic.
› Verified 5 days ago
| Provider Name | Ruth J Chen Od Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023777422 PECOS PAC ID: 5294127510 Enrollment ID: O20220119001025 |
News Archive
While many pharmaceutical and biologics companies are getting accustomed to FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) programs for many new and old drugs, most are not adequately preparing for the equally mandatory program evaluations beginning just 1-1/2 years after each REMS is put into effect.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering Atrial Fibrillation. These are the first guidelines to be prepared solely by the ESC on this very important topic.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Denise Gamboa, OD 1051 Solano Ave, Albany, CA 94706-1650 Ph: (510) 526-3937 | Denise Gamboa, OD 1051 Solano Ave, Albany, CA 94706-1650 Ph: (510) 526-3937 |
News Archive
While many pharmaceutical and biologics companies are getting accustomed to FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) programs for many new and old drugs, most are not adequately preparing for the equally mandatory program evaluations beginning just 1-1/2 years after each REMS is put into effect.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.
The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering Atrial Fibrillation. These are the first guidelines to be prepared solely by the ESC on this very important topic.
› Verified 5 days ago
Ruth J Chen Od Inc Optometrist Medicare: Medicare Enrolled Practice Location: 1051 Solano Ave, Albany, CA 94706 Phone: 510-526-3937 | |
Dr. Ruth J Chen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1051 Solano Ave, Albany, CA 94706 Phone: 510-526-3937 Fax: 510-526-6133 | |
Solano Eyecare Optometric Professionals Optometrist Medicare: Medicare Enrolled Practice Location: 1051 Solano Ave, Albany, CA 94706 Phone: 510-526-3937 Fax: 510-526-6133 | |
Thanhan Andy Nguyen-tran, OD, FAAO Optometrist Medicare: Medicare Enrolled Practice Location: 1051 Solano Ave, Albany, CA 94706 Phone: 510-526-3937 | |
Jennifer Juang, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1313 Solano Ave, Albany, CA 94706 Phone: 510-526-0194 | |
Albany Berkeley Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 1313 Solano Ave, Albany, CA 94706 Phone: 510-526-0194 Fax: 510-524-2370 |